Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $3.1 million.

  • AtriCure's Depreciation and Depletion rose 55.88% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 1190.25%. This contributed to the annual value of $11.2 million for FY2024, which is 1854.12% up from last year.
  • Latest data reveals that AtriCure reported Depreciation and Depletion of $3.1 million as of Q3 2025, which was up 55.88% from $3.1 million recorded in Q2 2025.
  • AtriCure's 5-year Depreciation and Depletion high stood at $3.1 million for Q2 2025, and its period low was $1.9 million during Q3 2021.
  • Over the past 5 years, AtriCure's median Depreciation and Depletion value was $2.4 million (recorded in 2023), while the average stood at $2.4 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first tumbled by 770.38% in 2021, then soared by 2611.94% in 2024.
  • Quarter analysis of 5 years shows AtriCure's Depreciation and Depletion stood at $1.9 million in 2021, then increased by 17.08% to $2.2 million in 2022, then rose by 13.81% to $2.5 million in 2023, then grew by 18.54% to $2.9 million in 2024, then increased by 4.01% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $3.1 million for Q2 2025, and $3.0 million during Q1 2025.